Australia markets closed

Xtant Medical Holdings, Inc. (XTNT)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.7500-0.0011 (-0.15%)
At close: 04:00PM EDT
0.7700 +0.02 (+2.67%)
After hours: 05:59PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-1,662
660
-8,485
-4,849
-7,023
-
Depreciation & amortisation
3,708
3,174
1,292
1,332
2,079
-
Deferred income taxes
-
-1,901
0
-
-
-
Stock-based compensation
3,032
2,739
2,464
2,209
1,084
-
Change in working capital
-5,764
-3,634
-2,811
793
-3,273
-
Accounts receivable
-8,460
-8,736
-3,941
-319
2,890
-
Inventory
-3,772
-1,886
-1,152
2,624
-5,792
-
Accounts payable
3,541
2,980
875
-332
101
-
Other working capital
-14,798
-10,971
-7,105
-1,676
-2,276
-
Other non-cash items
-11,257
-11,292
237
156
5,979
-
Net cash provided by operating activities
-13,025
-9,515
-5,341
439
-731
-
Cash flows from investing activities
Investments in property, plant and equipment
-1,773
-1,456
-1,764
-2,115
-1,545
-
Acquisitions, net
-6,503
-23,503
0
-
-
-
Net cash used for investing activities
-8,037
-24,784
-1,559
-1,890
-1,304
-
Cash flows from financing activities
Debt repayment
-84,966
-77,039
-54,520
-36,953
-471
-
Common stock issued
-
14,011
9,311
18,426
620
-
Other financing activities
-674
-261
-
-337
-1,058
-148
Net cash used provided by (used for) financing activities
20,301
19,691
9,020
17,497
-861
-
Net change in cash
-786
-14,584
2,120
16,046
-2,896
-
Cash at beginning of period
5,410
20,507
18,387
2,341
5,237
-
Cash at end of period
4,649
5,923
20,507
18,387
2,341
-
Free cash flow
Operating cash flow
-13,025
-9,515
-5,341
439
-731
-
Capital expenditure
-1,773
-1,456
-1,764
-2,115
-1,545
-
Free cash flow
-14,798
-10,971
-7,105
-1,676
-2,276
-